1 antiretroviral therapy in hiv-infected children haivn harvard medical school aids initiative in...
TRANSCRIPT
1
Antiretroviral Therapy in HIV-infected Children
HAIVNHarvard Medical School AIDS
Initiative in Vietnam
2
Learning Objectives
By the end of this session, participants should be able to:
Outline criteria for starting an HIV+ child on ARVs
Identify first line ARV regimens for children in Vietnam
Describe how to prepare ARV doses for children based on age, weight, and BSA
Propose recommendations to improve ARV adherence in children
3
Diagnosis of HIV Infection in Infants and Children
The earlier the better! Early diagnosis, and early ART, greatly
reduce mortality All PLWHA with children should be
encouraged to test their children for HIV Diagnostic protocol is divided into 3 age
groups: • 0-18 months• 9-18 months • > 18months
4
Flow Chart for PCR Testing in Infants < 9 Months
First PCR at 4-6 weeks of age
Second PCR as soon as possible
ELISA at 18 monthsChild is infected with
HIV
If infant is breastfeeding, repeat PCR after infant has stopped breastfeeding for 6 weeks
––––++
++
5
Diagnosing Children 9 to 18 Months and > 18 Months
For children 9-18 months:• Perform ELISA first
If positive, perform PCR as for children under 9 months
If negative, repeat ELISA at 18 months If breastfeeding, stop for 6 weeks before ELISA
testing. If ELISA positive, perform PCR
For children >= 18 months:• Perform ELISA
6
Cotrimoxazole Preventive Therapy
7
Cotrimoxazole Prophylaxis (1)
HIV-exposed children Confirmed HIV-infected children
•Start 4–6 weeks after birth•Continue until exclusion of HIV infection
< 24 months
24 – 60 months > 60 months
All Clinical stages 2, 3 and 4 regardless of CD4 count orCD4 < 25% or ≤ 750 cells/mm3 regardless of clinical stage
Clinical stage 3 or 4 regardless of CD4 count or CD4 ≤ 350 regardless of clinical stage
8
Cotrimoxazole Prophylaxis (2)
Discontinuation:
Alternative therapy: • If allergic to cotrimoxazole, use dapsone
2mg/kg/day once a day (100mg pill)
ART/no ART ActionIf not on ART lifelong therapy
If on ART discontinue when:• CD4 > 25% for 1-5 year-olds• CD4 > 350 for > 5 year-olds
9
Indications for the Initiation of
ARV Therapy
10
Classification of Immunodeficiency
Level of Immuno-deficienc
y
CD4% or cells/mm3
≤11 months
12–35 months
36 –59 months
≥ 5 years
None >35 % >30 % >25 %> 500
cells/mm3
Mild 30-35 % 25-30 % 20-25 %350 – 499 cells/mm3
Moderate 25-29 % 20-24 % 15-19 %200 – 349 cells/mm3
Severe<25 %<1500
cells/mm3
<20 %<750
cells/mm3
<15 %<350
cells/mm3
<15%<200
cells/mm3
11
Criteria for ART Initiation
Age Starting ART
< 24 monthsStart ART as soon as possible
(regardless of clinical stage or CD4)
24 - 60 months
Clinical stage 3 or 4 regardless of CD4 count
CD4% ≤ 25% or CD4 ≤ 750 cells/mm3 regardless of clinical stage
> 60 months Indications as per HIV-infected adults
12
First-line ARV Regimens
Age Starting ART
< 24 monthsNNRTI exposed: AZT + 3TC + LPV/r
NNRTI un-exposed: AZT + 3TC + NVP
24 - 36 months AZT + 3TC + NVP
> 36 months AZT + 3TC + NVP/EFV
In case of intolerance to AZT, change to ABC.If there is contraindication of ABC, use d4T
13
ARV Regimens Co-administered with TB Drugs
Children >3 years old and > 10kg
Children < 3 years old and < 10kg
AZT + 3TC + EFV
or
AZT+ 3TC + ABC
AZT + 3TC + NVP
or
AZT+ 3TC + ABC
Rifampicin lowers NVP levels; it’s preferable to use EFV when possible
14
ARV Dosing
15
ARV Dosing for Children
BSA (m2) = √ Weight (kg) x Height (cm)/3600
Two common ways: Weight-band dosing Body Surface Area (BSA)
*Weight and height should be recorded at every visit
16
Stavudine and Lamivudine
Lamivudine (3TC)
Suspension 10mg/ml
Tablet 150mg
4 mg/kg twice daily
Max 150mg
twice daily
Stavudine (Zerit, D4T)
Suspension 1mg/ml
Tablet 15, 20, 30mg
1 mg/kg twice daily
Max 30 mg twice
daily
17
Zidovudine (AZT)
Zidovudine (AZT)
Suspension 10mg/ml
Tablet 100, 300mg
180-240 mg/m2
twice daily
Max 300 mg/dose twice
daily
18
Nevirapine (NVP)
Nevirapine (NVP)Suspension 10mg/ml, Tablet 200mg
Lead-in Dose 160-200 mg/m2 daily x 14 days
Maintenance Dose
< 8 years: 200 mg/m2 twice daily
≥ 8 years: 160-200 mg twice daily
19
Efavirenz (EFV)
Use EFV in children > 3 years & weight ≥ 10kg
10 – 15 kg 200 mg once daily
15 – 20 kg 250 mg once daily
20 – 25 kg 300 mg once daily
25 – 33 kg 350 mg once daily
33 – 40 kg 400 mg once daily
> 40 kg 600 mg once daily
20
D4T Fixed Dose Combinations (FDC)
d4T-FDCs twice daily
d4T-6: tablet
d4T 6mg/ 3TC 30mg/ NVP 50mg (Triomune Baby)
• used for children < 15kg
d4T-12: tablet
d4T 12mg/ 3TC 60mg/ NVP 100mg (Triomune Junior)
• used for children < 30mg and > 12kg
d4T-30: tablet
d4T 30mg/ 3TC 150mg/ NVP 200mg • used for children ≥ 30mg
21
AZT Fixed Dose Combination (FDC)
AZT-FDCs twice daily
AZT-60: tablet
(AZT 60mg, 3TC 30mg, NVP 50mg)
• used for children< 25kg
AZT-300: tablet
(AZT 300mg, 3TC 150mg, NVP 200mg)
• used for children≥ 25kg
22
Preparing ARVs for Children
Syringes that can be snugly connected to the bottles can be used to draw up the exact amount of medication needed.
Use syringe to measure drugs. Do not use cups
23
Pediatric ARV Monitoring
Clinical• Physical growth, nutritional status - use
growth chart• Development – neurologic, cognitive,
social, psychological Social
• Support for caretakers• Evaluate adherence to PCP prophylaxis
and/or ARV
24
Laboratory Monitoring
TestsBaseline (at ART
initiation)
Follow-up
At 4 weeksAt 6
monthsAt 12
months
Every 6 months
thereafter
CD4, CD4%
CBC, ALT CBC if use AZT
ALT if use NVP
Pregnancy test for adolescent girls
If suspected
Viral load If available
25
Case Study 1
19-month-old HIV positive child is eligible for ART
His weight is 6 kg Write a correct prescription for this
child using a d4T-based regimen
26
D4T-Based Regimen: Weight 6 kg
Weightd4T
Syrup 1 mg/ml
3TCSyrup 10
mg/ml
NVPSyrup
10 mg/ml5.0 – 6.5 kg 6 ml twice a day 3 ml twice a day 6 ml once a day
Initial 14 days: Lead-in dose, Use individual drugs
Then, change to FDC:
WeightFDC d4T-6:
d4T 6mg, 3TC 30mg, NVP 50 mg Triomune Baby
6.0 – 6.5 kg 1½ tablets in morning and 1 tablet at night
27
Case Study 2
4 year old HIV positive child is eligible for ART
His weight is 18 kg Write a correct prescription for this
child using a AZT-based regimen
AZT-Based Regimen: Weight 18 kg
WeightAZT
Tablet 300 mg
3TCTablet 150 mg
orSyrup 10 mg/ml
NVPTablet 200 mg
17.0 - 19.9 kg
½ tablet twice per day
½ tablet twice a day or 8 ml syrup twice a day
1 tablet once per day
Initial 14 days: Lead-in dose, Use individual drugs
Then, change to FDC:
WeightFDC AZT-60:
AZT 60mg, 3TC 30mg, NVP 50mg14.0 - 19.9
kg2½ tablets twice per day
29
Case Study 3
6 year old HIV positive child, weight 22 kg
Has pulmonary TB and is on TB treatment
Write a correct prescription for this child using a AZT-based regimen
30
AZT and EFV - Based Regimen: Weight 22 kg
WeightAZT
Tablet 100 mg
3TCTablet 150 mg
EFVCapsule 50mg, 200
mg
20.0 - 24.9 kg
2 tablet twice per day
1 tablet in morning, ½ tablet in evening
1 capsule of 200mg and 2 capsules of
50mg once per day
Use EFV for patients on TB therapy (> 3 years old and ≥ 10 kg)
31
Adherence Techniques for Children
32
Adherence for Missed Doses
Clarify the history with the caretaker
Suggest solutions
Follow up Adherence
3 Steps to Address “Missed Doses”
33
Missed Doses: Clarify the History with Caretaker
Question to clarify: WHAT medicine(s) were missed ? HOW many dose(s) were missed ? WHEN were the dose(s) missed ? WHO was responsible to deliver the
medicines ? WHY did the caretaker think it
happened ?
34
Missed Doses: Suggested Solutions (1)
Hard to take medicines:
Complaint/Problem
Suggested Solution
Tastes terrible • give with food, fruit jam or honey• substitute crushed pills for suspension
Hard to swallow pills/capsules
• crush pills
GI side effects • combine with food• consider taking anti-nausea medicine
35
Missed Doses: Suggested Solutions (2)
Ways for caretaker to remember to give the medicine to the child:
Pick an event that is easy to link the medicine to
Give family a pill-box for tablets, when appropriate
Suggest they use an alarm clock for alerting when taking the medicines
36
Missed Doses: Follow up Adherence
Schedule a time for counseling staff to check adherence with the family and make plans for ongoing adherence support by:
Phone calls Clinic visits Home-care visits
37
Key Points
ARVs can be initiated in a child with a confirmed HIV infection
Preferred first line regimen in children is same as in adults: AZT/3TC/NVP
All medications in children are dosed according to child’s age and weight
Good pediatric adherence requires a team approach
38
Thank you!
Questions?